Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

A new approach to quantification of DTPA incorporation into monoclonal antibodies (MoAbs) labeled by the cyclic anhydride DTPA method

Conference · · J. Nucl. Med.; (United States)
OSTI ID:6856753
A method for determining the ratio of DTPA molecules attached per molecule of Ab was developed and used to examine the immunoreactivity of different Abs as a function of the amount of incorporated DTPA. The bicyclic anhydride of DTPA(2-C-14)acetic acid (BADTPA-C-14) was synthesized by reacting DTPA(2-C-14)acetic acid (1mCi/mmo1) and acetic anhydride. BADTPA-C-14 then was reacted with a MoAb to a melanoma associated antigen (MA) and to a MoAb to human HLA class II antigen (HLA) at 2mg/m1 of MoAb concentration, at MoAb to BADTPA-C-14 ratios (mmo1/mmo1) of l:1, 1:10, 1:00, l:200. The conjugate was dialyzed exhaustively against HEPES at pH 7.0. The MoAb concentration was measured at 280mm of uv; the DTPA/MoAb ratio was calculated based on the specific activity of BADTPA-C-14, and the immunoreactivity was assessed by direct cell-binding to melanoma, the HLA antigen and control (lymphoma) cells. Percent binding to the lymphoid cell line was less than 3%. The authors' results demonstrated a method for directly determining the number of DTPA molecules attached to a MOAb, and demonstrated variations in immunoreactivity as the number of DTPA groups per MoAb is altered.
Research Organization:
Columbia Univ., New York, NY
OSTI ID:
6856753
Report Number(s):
CONF-850611-
Conference Information:
Journal Name: J. Nucl. Med.; (United States) Journal Volume: 26:5
Country of Publication:
United States
Language:
English